Taro Pharmaceutical Industries Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of TARO for the last quarter is 157.15 M USD, and it's 6.03% higher compared to the previous quarter. The net income of Q3 23 is 20.21 M USD.